Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hinokitiol functions as a ferroptosis inhibitor to confer neuroprotection
Junmin Xi, Zhijun Zhang, Zuo Wang, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 202-215
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes
Yumin Wang, Shuang Wu, Qiang Li, et al.
Advanced Science (2023) Vol. 10, Iss. 24
Open Access | Times Cited: 71
Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 64
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 54
Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review
Zhao Da, Kailin Yang, Hua Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114312-114312
Open Access | Times Cited: 43
Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases
Yi Wang, Meng-nan Lv, Weijiang Zhao
Ageing Research Reviews (2023) Vol. 91, pp. 102035-102035
Open Access | Times Cited: 41
Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 13
Natural product-derived ferroptosis mediators
Yili Chen, Lin-An Xiong, Lie‐Feng Ma, et al.
Phytochemistry (2024) Vol. 219, pp. 114002-114002
Closed Access | Times Cited: 10
The Role of Calcium and Iron Homeostasis in Parkinson’s Disease
Ji Wang, Jindong Zhao, Kunying Zhao, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 88-88
Open Access | Times Cited: 9
Artemisinin ameliorates cognitive decline by inhibiting hippocampal neuronal ferroptosis via Nrf2 activation in T2DM mice
Bo Wang, Sheng Zhu, Miao Guo, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 9
Ferroptosis: A potential target for the intervention of intervertebral disc degeneration
Lu-Ping Zhou, Renjie Zhang, Chong-Yu Jia, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27
Research Models to Study Ferroptosis’s Impact in Neurodegenerative Diseases
Inês Costa, Daniel José Barbosa, Vera Silva, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1369-1369
Open Access | Times Cited: 18
Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products
Kailin Yang, Liuting Zeng, Jinsong Zeng, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102063-102063
Closed Access | Times Cited: 15
Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
Yingfan Chen, Zhenhui Wu, Shaodan Li, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 1053-1081
Open Access | Times Cited: 6
The molecular mechanism of ferroptosis and its relationship with Parkinson's disease
Yan Su, Yue Jiao, Sheng Cai, et al.
Brain Research Bulletin (2024) Vol. 213, pp. 110991-110991
Open Access | Times Cited: 6
A New Perspective in the Treatment of Ischemic Stroke: Ferroptosis
Lei Zhang, Xin Yue Bai, Ke Yao Sun, et al.
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 815-833
Closed Access | Times Cited: 5
NRF2 Inhibitors: Recent Progress, Future Design and Therapeutic potential
Bingbing Lv, Shuaishuai Xing, Zhiqiang Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116822-116822
Closed Access | Times Cited: 5
Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer
Md. Shimul Bhuia, Raihan Chowdhury, Meher Afroz, et al.
Chemistry & Biodiversity (2025)
Closed Access
Revealing rutaecarpine’s promise: A pathway to parkinson’s disease relief through PPAR modulation
Yeying Wang, Bin Liao, Xuesong Shan, et al.
International Immunopharmacology (2025) Vol. 147, pp. 114076-114076
Open Access
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases
Leilei Chen, Qingqing Shen, Yingjuan Liu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Hinokitiol ameliorates MASH in mice by therapeutic targeting of hepatic Nrf2 and inhibiting hepatocyte ferroptosis
Xunzhe Yin, Zuojia Liu, Chang Li, et al.
Phytomedicine (2025) Vol. 139, pp. 156472-156472
Closed Access
Advances in Ferroptosis Research: A Comprehensive Review of Mechanism Exploration, Drug Development, and Disease Treatment
Haojie Wang, Yuanyuan Xie
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 334-334
Open Access
Thirty years of NRF2: advances and therapeutic challenges
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access
General Approach to Identify, Assess, and Characterize Inhibitors of Lipid Peroxidation and Associated Cell Death
Melodie Mallais, Carly S. Hanson, Melanie Giray, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 3, pp. 561-571
Closed Access | Times Cited: 9
Protective Effects of Hinokitiol on Neuronal Ferroptosis by Activating the Keap1/Nrf2/HO-1 Pathway in Traumatic Brain Injury
Hongxing Tang, Kejun He, Kun Zhao, et al.
Journal of Neurotrauma (2023) Vol. 41, Iss. 5-6, pp. 734-750
Closed Access | Times Cited: 9
Hinokitiol protects gastric injury from ethanol exposure via its iron sequestration capacity
Mengran Zhao, Chen Qiao, Shuyue Yang, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176340-176340
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top